SC 13D Filing

Company

Akari Therapeutics Plc

Filed

June 18, 2024

Accession Number

0000908834-24-000173

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →